September 15, 2014

While Google and Alcon figure out the next wireless 007-style eyewear to help manage diabetes, there are device manufacturers today who are developing next-generation blood-glucose meters. 

September 15, 2014

Close to half (40%) of the U.S. adult population — roughly 126 million — is expected to develop Type 2 diabetes at some point during their lifetime, according to a study published in The Lancet Diabetes and Endocrinology in August.

September 15, 2014

Thanks to the Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System, the diabetes community stands to play a significant role in how pharmacies think about their patients and their medication adherence programs. 

September 15, 2014

Managing such chronic conditions as diabetes has become a core competency among many retail pharmacies. It dovetails well with the retail pharmacy industry’s goal to become a destination center for patients proactively seeking to improve their health and wellness.

September 15, 2014

Two U.S. hospitals are preparing to launch trials with diabetics and chronic disease patients using Apple's HealthKit, according to a Reuters report published Monday morning. 

September 15, 2014

Sales of the popular Type 2 diabetes drug metformin may get a boost if physicians begin prescribing the medicine as a prophylactic in people who don’t have diabetes. A recent study published in the diabetes journal Diabetes, Obesity and Metabolism and conducted by scientists from Cardiff University found that patients treated with metformin could live longer than people without diabetes.

September 15, 2014

Dick Tracy has nothing on the wearable gadgets under development to help people better police their diabetes. Wearable technologies in its totality — which include Google Glass and the Apple Watch — are part of a booming market that’s expected to swell to $20 billion by 2015 and is further expected to grow at a compound annual growth rate of nearly 40% over the next six years.

September 9, 2014

AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.

September 5, 2014

Univision on Thursday announced the official sponsors for its singing reality competition, “Va Por Ti” (This One’s For You) , a co-production of Televisa and Univision. 

September 3, 2014

Abbott on Wednesday announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose-sensing technology for people with diabetes. 

September 3, 2014

To help encourage early detection of diabetes in communities around the United States, Sam’s Club Pharmacy will host free diabetes screenings to both members and non-members on Sept. 13.

August 27, 2014

"The diabetic is a critically important patient for pharmacies to serve. Yet, with increased Medicare audits, stringent compliance requirements and reduced reimbursements, is servicing these patients really worth it?" writes Kevin Dore, a director at Emdeon, in his latest blog.

August 26, 2014

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. announced that Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States.

August 25, 2014

DSN presents a preview of some of the hottest OTC products that appear on the show floor at NACDS Total Store Expo.

August 25, 2014

Nipro Diagnostics announced that the Food and Drug Administration approved its True Metrix self-monitoring blood-glucose system, as well as the True Metrix Pro professional monitoring blood-glucose system.

August 21, 2014

The Food and Drug Administration cleared South Korean company Philosys’ Gmate blood-sugar monitoring device for U.S. marketing on Aug. 15.

August 20, 2014

iHealth Lab recently launched its iHealth Align, one of the world’s smallest, FDA-approved mobile blood-glucose monitors.

August 19, 2014

The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.

August 13, 2014

This year, thousands of people in communities across the country are expected to join the millions in the fight to stop diabetes by participating in the American Diabetes Association's Step Out: Walk to Stop Diabetes fundraising event.

August 11, 2014

Janssen Pharmaceuticals received approval from the Food and Drug Administration for Invokamet, a fixed-dose therapy that combines canagliflozin and metformin hydrochloride in a single tablet.

August 11, 2014

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

August 6, 2014

BD Medical, a segment of BD, on Wednesday announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front- and back-end shields that provides greater convenience and safety before and after injecting. 

August 1, 2014

The Food and Drug Administration announced approval for Boehringer Ingelheim's Jardiance tablets.

July 30, 2014

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.